1. Home
  2. HUDI vs TOVX Comparison

HUDI vs TOVX Comparison

Compare HUDI & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huadi International Group Co. Ltd.

HUDI

Huadi International Group Co. Ltd.

HOLD

Current Price

$0.68

Market Cap

11.5M

Sector

Industrials

ML Signal

HOLD

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.22

Market Cap

9.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUDI
TOVX
Founded
1998
2001
Country
China
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
9.8M
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
HUDI
TOVX
Price
$0.68
$0.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
25.8K
1.2M
Earning Date
01-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
89.07
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.16
52 Week High
$5.46
$0.86

Technical Indicators

Market Signals
Indicator
HUDI
TOVX
Relative Strength Index (RSI) 29.90 41.20
Support Level N/A $0.20
Resistance Level $1.31 $0.22
Average True Range (ATR) 0.06 0.01
MACD -0.01 -0.00
Stochastic Oscillator 0.48 31.18

Price Performance

Historical Comparison
HUDI
TOVX

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: